These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16521807)

  • 1. [Treatment for cancer specifically diagnosed in high-aged population, prostate cancer].
    Miki T
    Nihon Ronen Igakkai Zasshi; 2006 Jan; 43(1):71-3. PubMed ID: 16521807
    [No Abstract]   [Full Text] [Related]  

  • 2. The prostate cancer conundrum.
    Albertsen PC
    J Natl Cancer Inst; 2003 Jul; 95(13):930-1. PubMed ID: 12837821
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate cancer update.
    Rosenberg J; Small EJ
    Curr Opin Oncol; 2003 May; 15(3):217-21. PubMed ID: 12778015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of patients with prostate cancer: the nurse's role.
    Turner B
    Nurs Stand; 2007 Jun 6-12; 21(39):48-56; quiz 58. PubMed ID: 17569378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What your patient needs to know about prostate cancer.
    Held-Warmkessel J
    Nursing; 2002 Dec; 32(12):36-42; quiz N232. PubMed ID: 12468938
    [No Abstract]   [Full Text] [Related]  

  • 6. [Modern therapy of prostate cancer].
    Kretschmer A; Stief C; Gratzke C
    MMW Fortschr Med; 2014 Dec; 156(21-22):71-3. PubMed ID: 25608415
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinics in prostate cancer].
    Sugimura Y
    Rinsho Byori; 2004 Jul; 52(7):604-10. PubMed ID: 15344560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer.
    Hennenfent BR
    Br J Urol; 1998 Jul; 82(1):166. PubMed ID: 9698691
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant therapy for pathologic stage C prostate cancer: a casualty of the PSA revolution?
    Anscher MS
    Int J Radiat Oncol Biol Phys; 1996 Feb; 34(3):745-7. PubMed ID: 8621301
    [No Abstract]   [Full Text] [Related]  

  • 10. Combating prostate cancer.
    Garnick MB; Fair WR
    Sci Am; 1998 Dec; 279(6):74-83. PubMed ID: 9828467
    [No Abstract]   [Full Text] [Related]  

  • 11. What PCPs and geriatricians need to know about robotic prostatectomy and organ-confined prostate cancer.
    Carlucci JR; Nabizada-Pace F; Samadi DB
    Geriatrics; 2009 Feb; 64(2):8-14. PubMed ID: 19256581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Adverse Pathology and Undetectable Ultrasensitive Prostate-Specific Antigen after Radical Prostatectomy: Is Adjuvant Radiation Warranted?
    Taneja SS
    J Urol; 2015 Dec; 194(6):1631-2. PubMed ID: 26582665
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancer.
    Fu AZ; Tsai HT; Haque R; Ulcickas Yood M; Van Den Eeden SK; Cassidy-Bushrow AE; Zhou Y; Keating NL; Smith MR; Aaronson DS; Potosky AL
    World J Urol; 2016 Dec; 34(12):1611-1619. PubMed ID: 27084777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum prostate-specific antigen elevation in the post-radical prostatectomy patient.
    Malkowicz SB
    Urol Clin North Am; 1996 Nov; 23(4):665-75. PubMed ID: 8948419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Conference on the treatment of prostatic cancer. Munich, Germany, 2-3 November 1996].
    Lansiaux P
    Prog Urol; 1997 Dec; 7(6):1020-2. PubMed ID: 9490132
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence-based clinical practice Guidelines for Prostate Cancer (Summary - JUA 2006 Edition).
    Kamidono S; Ohshima S; Hirao Y; Suzuki K; Arai Y; Fujimoto H; Egawa S; Akaza H; Hara I; Hinotsu S; Kakehi Y; Hasegawa T;
    Int J Urol; 2008 Jan; 15(1):1-18. PubMed ID: 18184166
    [No Abstract]   [Full Text] [Related]  

  • 17. This paper evaluates the natural history of prostate cancer in heterogeneous cohort of men treated with HT.
    Yossepowitch O
    Eur Urol; 2007 Aug; 52(2):453. PubMed ID: 17674435
    [No Abstract]   [Full Text] [Related]  

  • 18. Active surveillance for favorable-risk prostate cancer: what are the results and how safe is it?
    Klotz L
    Curr Urol Rep; 2007 Sep; 8(5):341-4. PubMed ID: 17880830
    [No Abstract]   [Full Text] [Related]  

  • 19. Endocrine treatment: expected duration stage by stage.
    Schröder FH
    Prostate Suppl; 2000; 10():26-31. PubMed ID: 11056490
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of androgen deprivation and salvage radiation therapy for patients with prostate cancer and biochemical recurrence after prostatectomy.
    Ghadjar P; Aebersold DM; Albrecht C; Böhmer D; Flentje M; Ganswindt U; Höcht S; Hölscher T; Sedlmayer F; Wenz F; Zips D; Wiegel T;
    Strahlenther Onkol; 2018 Jul; 194(7):619-626. PubMed ID: 29383406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.